| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pioneering Medicines 02, LLC | 10%+ Owner | 55 CAMBRIDGE PARKWAY,, SUITE 800E, CAMBRIDGE | Pioneering Medicines 02, LLC, By: /s/ Charles R. Carelli, Jr., Manager | 12 Mar 2026 | 0002117576 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | GENB | Common Stock | 1,562,500 | 02 Mar 2026 | By Pioneering Medicines 02, LLC | F1 |
| Id | Content |
|---|---|
| F1 | Securities held by Pioneering Medicines 02, LLC ("PM02"). Charles R. Carelli, Jr., Chief Financial Officer of Flagship Pioneering, LLC ("Flagship Pioneering"), is the sole manager of PM02, and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") is its majority equity holder. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. The Reporting Person disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any. |